IPP Bureau

FUJIFILM brings next-gen AI-enabled digital mammography platform to India
FUJIFILM brings next-gen AI-enabled digital mammography platform to India

By IPP Bureau - June 09, 2026

First installation of AI-powered AMULET SOPHINITY at NM Medical aims to strengthen early breast cancer detection

Merck signs MoU with CSIR-IICT to strengthen industry-academia ties
Merck signs MoU with CSIR-IICT to strengthen industry-academia ties

By IPP Bureau - June 09, 2026

The collaboration will foster joint research initiatives, scientific knowledge exchange, and innovation

Lilly’s oral GLP-1 drug Orforglipron outperforms Semaglutide in phase 3 diabetes trial
Lilly’s oral GLP-1 drug Orforglipron outperforms Semaglutide in phase 3 diabetes trial

By IPP Bureau - June 09, 2026

Based on the cumulative data from ACHIEVE-1 through ACHIEVE-5, Lilly plans to submit orforglipron for FDA approval for the treatment of type 2 diabetes by the end of the second quarter

Agilus’s Idylla claims to deliver cancer mutation results in just 3 hours
Agilus’s Idylla claims to deliver cancer mutation results in just 3 hours

By IPP Bureau - June 09, 2026

Advanced molecular diagnostics solution enables rapid, high-accuracy biomarker detection for precision oncology

Punita Kumar-Sinha appointed Independent Director at Aurobindo Pharma USA
Punita Kumar-Sinha appointed Independent Director at Aurobindo Pharma USA

By IPP Bureau - June 09, 2026

Seasoned governance expert and board leader brings extensive experience in strategic oversight, risk management, and corporate governance across multiple sectors

Medtronic secures CE Mark for Stealth AXiS surgical navigation system in Europe
Medtronic secures CE Mark for Stealth AXiS surgical navigation system in Europe

By IPP Bureau - June 09, 2026

New-generation platform enhances anatomical visualization, streamlines surgical workflows, and expands access to advanced navigation technology for ENT surgeons across Europe

Yashoda Medicity gets DGME approval for brain stem death certification committee
Yashoda Medicity gets DGME approval for brain stem death certification committee

By IPP Bureau - June 09, 2026

The newly constituted committee will facilitate timely brain stem death certification, supporting transparent organ donation processes and expanding opportunities for patients awaiting transplants

Bayer brings Alka-Seltzer to India touting first antacid with probiotic support
Bayer brings Alka-Seltzer to India touting first antacid with probiotic support

By IPP Bureau - June 09, 2026

The launch comes against the backdrop of a significant public health burden

DENSTAR project launched to fast-track dengue vaccine licensure in Africa
DENSTAR project launched to fast-track dengue vaccine licensure in Africa

By IPP Bureau - June 09, 2026

Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa

FDA expands Pfizer’s HYMPAVZI approval
FDA expands Pfizer’s HYMPAVZI approval

By IPP Bureau - June 09, 2026

Broadening access for children & patients with inhibitor-complicated hemophilia

AbbVie showcases broad blood cancer pipeline at EHA 2026 with 21 presentations
AbbVie showcases broad blood cancer pipeline at EHA 2026 with 21 presentations

By IPP Bureau - June 09, 2026

The company will present 21 oral and poster presentations spanning investigational and approved therapies

Mariska Hargitay launches Bristol Myers Squibb's Myeloma Awareness Campaign
Mariska Hargitay launches Bristol Myers Squibb's Myeloma Awareness Campaign

By IPP Bureau - June 09, 2026

The campaign places renewed focus on a disease that remains incurable despite major scientific advances

Lilly’s “triple agonist” drug delivers striking weight loss & broad health gains in late-stage trials
Lilly’s “triple agonist” drug delivers striking weight loss & broad health gains in late-stage trials

By IPP Bureau - June 09, 2026

Researchers say the results point to a potential shift in how obesity is treated—as a central disease driving multiple conditions, rather than a collection of separate problems

Lupin Manufacturing Solutions appoints Eduardo Jule as Chief Commercial Officer
Lupin Manufacturing Solutions appoints Eduardo Jule as Chief Commercial Officer

By IPP Bureau - June 08, 2026

Veteran pharma and biotech executive brings over 20 years of commercial leadership experience to support LMS's global CDMO and API growth strategy

Smile Foundation delivers 20 lakh healthcare treatments in FY26
Smile Foundation delivers 20 lakh healthcare treatments in FY26

By IPP Bureau - June 08, 2026

Community healthcare initiatives reach a milestone year, with services spanning 90 districts, 22 states, and over 70 lakh cumulative beneficiaries since 2006

Latest Stories

Interviews

Packaging